Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy

Kirsty McNeil; Sarah Savaridas

Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy

Kirsty McNeil
, Sarah Savaridas (Lead / Corresponding author)

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - Oct 2024
Event	EUSOBI Annual Scientific Meeting 2024 - Lisbon, Portugal Duration: 3 Oct 2024 → 5 Oct 2024 https://www.eusobi.org/congress/

Conference

Conference	EUSOBI Annual Scientific Meeting 2024
Country/Territory	Portugal
City	Lisbon
Period	3/10/24 → 5/10/24
Internet address	https://www.eusobi.org/congress/

Keywords

Neoadjuvant systemic therapy evaluation

Cite this

@conference{d35e710ee28d474da18b27188c0023f5,

title = "Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy",

keywords = "Neoadjuvant systemic therapy evaluation",

author = "Kirsty McNeil and Sarah Savaridas",

year = "2024",

month = oct,

language = "English",

note = "EUSOBI Annual Scientific Meeting 2024 ; Conference date: 03-10-2024 Through 05-10-2024",

url = "https://www.eusobi.org/congress/",

}

Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy. / McNeil, Kirsty ; Savaridas, Sarah (Lead / Corresponding author).
2024. Poster session presented at EUSOBI Annual Scientific Meeting 2024, Lisbon, Portugal.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy

AU - McNeil, Kirsty

AU - Savaridas, Sarah

PY - 2024/10

Y1 - 2024/10

KW - Neoadjuvant systemic therapy evaluation

UR - https://eusobi2024.smart-abstract.com/eposter/#/posters/86

M3 - Poster

T2 - EUSOBI Annual Scientific Meeting 2024

Y2 - 3 October 2024 through 5 October 2024

ER -

Enhancing Tumour Volume as assessed on end of treatment MRI as a predictor of disease free survival in patients treated with neoadjuvant chemotherapy

Conference

Keywords

Other files and links

Cite this